A series of new oxoquinoline-imidazole derivatives (IMD1-IMD4) was prepared, and they were characterized by analytical and spectral data. Further, they were employed as effective fluorescence signaling switches through "OFF-ON" and "ON-OFF" by an ESIPT (excited-state intramolecular proton-transfer) mechanism. The OFF-ON green fluorescence exhibited by IMD1 selectively at 486 nm with Zn 2 + and F À is the basis for the determination of Zn 2 + and F À ions by way of detection limits of 5.28 × 10 À 9 M and 1.74 × 10 À 10 M, respectively. In contrast, IMD3 being fluorescent active (ON) with blue emission at 464 nm selectively exhibits quenching in fluorescence intensity in the presence of Fe 3 + and picric acid (PA) at pH 7.4. This quenching property of IMD3 leads to the rapid determination of Fe 3 + and picric acid (PA) selectively with a limit of detection of 3.28 × 10 À 9 M and 1.63 × 10 À 10 M, respectively. Experimental findings have been well-complemented by Density Functional Theory (DFT) studies. The activity of the synthesized oxoquinolineimidazole compounds (IMD1 and IMD3) was demonstrated on HeLa (Henrietta Lacks, a human cell line) and breast cancer cells for the detection of Zn 2 + and Fe 3 + ions, respectively.